Cytokinetics (CYTK) Depreciation and Depletion (2016 - 2018)
Cytokinetics (CYTK) posted quarterly Depreciation and Depletion of -$359000.0 for Q4 2018, down 160.85% year-over-year from $590000.0 in Q4 2017, and down 233.96% quarter-over-quarter from $268000.0 in Q3 2018.
Cytokinetics (CYTK) Depreciation and Depletion (2016 - 2018) Analysis & Trends
Cytokinetics (CYTK) has reported Depreciation and Depletion for 3 consecutive years, with -$359000.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Depreciation and Depletion fell 160.85% year-over-year to -$359000.0; the TTM figure through Dec 2018 stood at $1.2 million (down 36.84% YoY), while the FY2025 annual figure was $10.1 million, up 6.32% from the prior year.
- Depreciation and Depletion slipped to -$359000.0 in Q4 2018 per CYTK's latest filing, from $268000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $673000.0 in Q1 2018 and bottomed at -$359000.0 in Q4 2018.
- Historically, Depreciation and Depletion has averaged $364777.8 across 3 years, with a median of $439000.0 in 2017.
- Annual changes were most pronounced in 2017 — Depreciation and Depletion jumped 222.4% — and 2018, when it slumped 160.85%.
- Cytokinetics' Depreciation and Depletion stood at $183000.0 in 2016, then surged by 222.4% to $590000.0 in 2017, then plunged by 160.85% to -$359000.0 in 2018.
- Business Quant data shows CYTK's Depreciation and Depletion at -$359000.0 in Q4 2018, $268000.0 in Q3 2018, and $618000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -359,000.00 |
| Dec 31, 2018 | -359,000.00 |
| Sep 30, 2018 | 268,000.00 |
| Sep 30, 2018 | 268,000.00 |
| Jun 30, 2018 | 618,000.00 |
| Jun 30, 2018 | 618,000.00 |
| Mar 31, 2018 | 673,000.00 |
| Mar 31, 2018 | 673,000.00 |
| Dec 31, 2017 | 590,000.00 |
| Dec 31, 2017 | 590,000.00 |
| Sep 30, 2017 | 450,000.00 |
| Sep 30, 2017 | 450,000.00 |
| Jun 30, 2017 | 439,000.00 |
| Jun 30, 2017 | 439,000.00 |
| Mar 31, 2017 | 421,000.00 |
| Mar 31, 2017 | 421,000.00 |
| Dec 31, 2016 | 183,000.00 |
| Dec 31, 2016 | 183,000.00 |